Peter Lassoff

Dr Peter Lassoff Pharm.D., FTOPRA, has over 35 years’ experience within global regulatory affairs. Peter has deep domain expertise in regulatory affairs and drug/device development, and has established and grown businesses in the regulatory and medical writing outsourcing sectors on a global basis. Peter was most recently the Senior VP, Head of Regulatory, Medical Writing and Reg Intel for Syneos Health.

Peter joined Syneos Health in 2020 after many years in senior regulatory posts within the pharmaceutical and CRO industries. He is an American with a Pharm.D. from USC, and has worked in the UK for BMS and for the research division of Stiefel Laboratories. Within BMS, he worked for the pharmaceutical division and for ConvaTec, their medical devices subsidiary. Peter worked for Parexel where he ran their European regulatory group and most recently was Head of Global Regulatory Affairs for IQVIA (Quintiles). He has experience within a global R&D headquarters, with project leadership and management roles.

Peter provides experience and expertise in the development and worldwide registration of dermatological products, ‘borderline’ products, medical devices, cosmetics and ‘cosmeceuticals’, nutritional supplements and other regulated health-care products. Peter evaluates technologies or companies for acquisition with respect to cost of bringing the products to market, likelihood of registration, and costs involved with updating or optimising dossiers for worldwide registration.

Peter is a Fellow of TOPRA, the professional society for regulatory affairs; is on the Board of Supervisors for the University of Southern California's regulatory affairs programme and has won a lifetime achievement award for regulatory affairs.